|
国际皮肤性病学杂志 2006 32 (6): 383-385 ISSN: 2096-5540 CN: 32-1880/R |
|
|
|
|
|
肥大细胞增生症的研究进展 |
李红, 高琳, 沈柱, 高天文, 刘玉峰 |
第四军医大学西京医院全军皮肤性病中心, 西安710032 |
收稿日期 2006-03-29 修回日期 null 网络版发布日期 null |
参考文献 [1] Dirnhofer S,Zimpfer A,Went P.The diagnostic and predictive role of kit (CD117).Ther Umsch,2006,63:273-278. [2] Miettinen M,Lasota J.KIT (CD117):a review on expression in normal and neoplastic tissues,and mutations and their clinicopathologic correlation.Appl Immunohistochem Mol Morphol,2005,13:205-220. [3] Zappulla JP,Dubreuil P,Desbois S,et al.Mastocytosis in mice expressing human Kit receptor with the activating Asp816Val mutation.J Exp Med,2005,202:1635-1641. [4] Yanagihori H,Oyama N,Nakamura K,et al.c-kit Mutations in patients with childhood-onset mastocytosis and genotype-phenotype correlation.J Mol Diagn,2005,7:252-257. [5] Longley BJ Jr,Metcalfe DD,Tharp M,et al.Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis.Proc Natl Acad Sci U S A,1999,96:1609-1614. [6] Taylor ML,Sehgal D,Raffeld M,et al.Demonstration that mast cells,T cells,and B cells bearing the activating kit mutation D816V occur in clusters within the marrow of patients with mastocytosis.J Mol Diagn,2004,6:335-342. [7] Ben-Amitai D,Metzker A,Cohen HA.Pediatric cutaneous mastocytosis:a review of 180 patients.Isr Med Assoc J,2005,7:320-322. [8] James WV,Nancy LH,Richard D B.The World Health Organization classification of the myeloid neoplasns.Blood,2002,100:2292-2301. [9] Hartmann K,Henz BM.Classification of cutaneous mastocytosis:a modified consensus proposal.Leukemia Research,2002,26,483-484. [10] Valent P,Horny HP,Escribano L,et al.Diagnostic criteria and classification of mastocytosis:a consensus proposal.Leuk Res,2001,25:603-625. [11] Wolff K,Komar M,Petzelbauer P.Clinical and histopathological aspects of cutaneous mastocytosis.Leuk Res,2001,25:519-528. [12] Horny HP,Sotlar K,Stellmacher F,et al.An unusual case of systemic mastocytosis associated with chronic lymphocytic leukaemia (SM-CLL).J Clin Pathol,2006,59:264-268. [13] Florian S,Krauth MT,Simonitsch-Klupp I,et al.Indolent systemic mastocytosis with elevated serum tryptase,absence of skin lesions,and recurrent severe anaphylactoid episodes.Int Arch Allergy Immunol,2005,136:273-280. [14] Sotlar K,Horny HP,Simonitsch I,et al.CD25 indicates the neoplastic phenotype of mast cells:a novel immunohistochemical marker for the diagnosis of systemic mastocytosis (SM) in routinely processed bone marrow biopsy specimens.Am J Surg Pathol,2004,28:1319-1325. [15] Pardanani A,Kimlinger T,Reeder T,et al.Bone marrow mast cell immunophenotyping in adults with mast cell disease:a prospective study of 33 patients.Leuk Res,2004,28:777-783. |
|
|
|
通讯作者: |
|